PALISADE CAPITAL MANAGEMENT, LP

Position in KRYS — Krystal Biotech, Inc.

CIK 1009006 FORT LEE, NJ

Position in KRYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,740,858

New position

Shares Held

10,065

first reported quarter

Ownership

0.034%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#128

of 419 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 88% Shared 0% None 12%

Healthcare · as of Jun 30, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $15,917,613 across 3 Biotechnology names. KRYS ranks #3 (23.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	25,138	$6,153,028
2	LGND	Ligand Pharmaceuticals Inc	19,057	$6,023,727
3	KRYS	Krystal Biotech, Inc. This page	10,065	$3,740,858

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,740,858	10,065	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.